Is NXGL stock a Buy, Sell, or Hold?

Based on our analysis, NXGL is currently a HOLD with moderate confidence. 📊 HOLD: NXGL shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of NXGL stock?

Our analysis estimates the fair value range for NXGL to be between $0.54 and $0.60. The current price is $0.52.

What is the analyst price target for NXGL?

The average Wall Street analyst price target for NXGL is $2.00. This implies a potential upside of 284.7% from current levels.

NXGL Stock Analysis: Buy, Sell, or Hold?

NXGL - NexGel, Inc Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

$0.52

0.01 (1.01%) ▲

5d: -8.14%

30d: -14.49%

90d: -25.73%

HOLD

MODERATE Confidence

Analysis Updated: Jun 26, 2026 12:00 AM ET

Earnings: Aug 11, 2026

Get Alerted When NXGL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: NXGL shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 10.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$3.19

Based on 7.0% avg growth

INTRINSIC VALUE TODAY

$1.98

73.8% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.7x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: NXGL is currently trading at $0.52, which is considered oversold relative to its 30-day fair value range of $0.54 to $0.60. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.3) compared to its historical average (5.7). Remarkably, the market is currently pricing in an annual earnings decline of 38.8% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, NXGL is in a strong downtrend. The price is currently testing key support at $0.53. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: NXGL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.00 (+284.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Historical Trading Range $0.54 - $0.60

Company Quality Score 45/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.1%

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 284.7% below Wall St target ($2.00)
CAUTION: 5-day price weakness (-8.1%) - monitor closely

Trading Range Analysis

30-Day Trading Range $0.54 - $0.60

Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $0.53

Resistance Level $0.63

Current Trend Strong Downtrend

Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) 1.30

Wall Street Target $2.00 (+284.7%)

Revenue Growth (YoY) -5.6%

Profit Margin -28.5%

Valuation Discount vs History -38.8% cheaper

PE vs Historical 1.3 vs 5.7 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -38.8% (market-implied from PE analysis)

1-Year Target $0.47 (-10%)

2-Year Target $0.42 (-19%)

3-Year Target $0.38 (-27%)

3-Yr Target (if PE normalizes) (PE: 1→6) $1.66 (+220%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 1.3 to 5.7

Stabilization Target: $2.28 (+338.5%)

PE Expansion Potential: +338.5%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: June 27, 2026 4:45 PM ET
Data refreshes hourly during market hours. Next update: 5:45 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is NXGL showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for NXGL.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
ISRG Intuitive Surgical Inc	BUY 33 analysts	$565	59 HOLD
ALC Alcon AG	STRONG BUY 27 analysts	$88	60 HOLD
RMD ResMed Inc	BUY 19 analysts	$262	67 BUY
RGEN Repligen Corporation	STRONG BUY 19 analysts	$176	52 HOLD
COO The Cooper Companies, Inc	BUY 19 analysts	$81	66 BUY

ISRG Intuitive Surgica…

RGEN Repligen Corporat…

52 HOLD

COO The Cooper Compan…

66 BUY

More Analysis for NXGL

NXGL Technical Chart NXGL Price Prediction NXGL Earnings Date NXGL Investment Advisor NXGL Fair Price Analyzer NXGL Competitors

Compare NXGL with Peers

NXGL vs BTBD
Which one to buy?

NXGL vs HTCR
Which one to buy?

NXGL vs IMMX
Which one to buy?

NXGL vs BBLG
Which one to buy?

NXGL vs NRSN
Which one to buy?

NXGL vs IMMX
Winner: IMMX

NXGL vs RMD

NXGL vs NRSN
Winner: Tie

NXGL vs AVR

NXGL vs PLSE

Create New Comparison View All Competitors

Tradestie